Detalhe da pesquisa
1.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
; 385(9962): 43-54, 2015 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25230593
2.
Edge Vascular Response After Resorption of the Everolimus-Eluting Bioresorbable Vascular Scaffoldã- A 5-Year Serial Optical Coherence Tomography Study.
Circ J
; 80(5): 1131-41, 2016 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-26936236
3.
Temporal evolution of strut light intensity after implantation of bioresorbable polymeric intracoronary scaffolds in the ABSORB cohort B trial-an application of a new quantitative method based on optical coherence tomography.
Circ J
; 78(8): 1873-81, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24942012
4.
Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy?
Eur Heart J
; 33(11): 1325-33, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22507972
5.
ABSORB II randomized controlled trial: a clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: rationale and study design.
Am Heart J
; 164(5): 654-63, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23137495
6.
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.
Circ J
; 76(7): 1616-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531596
7.
A comparative assessment by optical coherence tomography of the performance of the first and second generation of the everolimus-eluting bioresorbable vascular scaffolds.
Eur Heart J
; 32(3): 294-304, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21123276
8.
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation
; 122(22): 2301-12, 2010 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098436
9.
Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials.
Eur Heart J
; 31(9): 1071-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20118171
10.
Evaluation of the XIENCE V everolimus eluting coronary stent system in the Asian population of the SPIRIT V single arm study. 2-year clinical follow-up data.
Indian Heart J
; 63(5): 402-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-23550416
11.
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods.
Lancet
; 373(9667): 897-910, 2009 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19286089
12.
IVUS radiofrequency analysis in the evaluation of the polymeric struts of the bioabsorbable everolimus-eluting device during the bioabsorption process.
Catheter Cardiovasc Interv
; 75(6): 914-8, 2010 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20091822
13.
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study.
Catheter Cardiovasc Interv
; 76(5): 634-42, 2010 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20690152
14.
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.
Lancet
; 371(9616): 899-907, 2008 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342684
15.
Quantification of coronary plaque by 64-slice computed tomography: a comparison with quantitative intracoronary ultrasound.
Invest Radiol
; 43(5): 314-21, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18424952
16.
Vasomotor Response to Nitroglycerine Over 5 Years Follow-Up After Everolimus-Eluting Bioresorbable Scaffold Implantation.
JACC Cardiovasc Interv
; 10(8): 786-795, 2017 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28427595
17.
Long-term serial non-invasive multislice computed tomography angiography with functional evaluation after coronary implantation of a bioresorbable everolimus-eluting scaffold: the ABSORB cohort B MSCT substudy.
Eur Heart J Cardiovasc Imaging
; 18(8): 870-879, 2017 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329198
18.
Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy.
JACC Cardiovasc Interv
; 10(1): 42-49, 2017 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017311
19.
Prediction of atherosclerotic disease progression using LDL transport modelling: a serial computed tomographic coronary angiographic study.
Eur Heart J Cardiovasc Imaging
; 18(1): 11-18, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26985077
20.
The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
J Am Coll Cardiol
; 46(4): 592-8, 2005 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-16098421